Covisian Acquires CX Management Company Centrinex
Strategic acquisition expands Covisian's presence in the U.S.; introduces GenAI capabilities to improve the "last mile" of customer interactions
NEW YORK, November 04, 2024--(BUSINESS WIRE)--Covisian Group, a technology company specializing in providing services and technologies to improve customer experiences (CX) globally, has announced the acquisition of Centrinex, a 600-employee contact center management company based in Lenexa, Kansas.
Terms of the deal were not disclosed.
Covisian owns and operates 46 contact center management sites across Europe and South America, handling more than 1 million customer interactions daily. Covisian, with its primary tech hub in New York, now adds a CX management location in the U.S., bringing with it a diversified portfolio of end customers across financial services, healthcare, transportation and other industries.
"Working under the umbrella of the Covisian Group will allow us to continue to modernize our operations and embrace technologies that elevate the customer experience," said Bart N. Miller, CEO, Centrinex. "The application of AI-enabled CX solutions along with our highly skilled agent base gives us a competitive edge in the market."
A Diversified Business
Covisian also operates the most important private healthcare customer care platform in Italy and has launched the industry's first GenAI-enabled CX software platform, Smile.CX, that expertly blends high-touch human support with automated, AI-driven administrative functions.
The Smile.CX platform is used by both Covisian-owned BPOs and standalone contact centers to amplify human intelligence and empathy while harnessing the efficiency of AI, ensuring unparalleled customer experiences, satisfaction, productivity and efficiency. With Smile.CX, contact centers have unlimited flexibility and can better personalize CX experiences to transform the critical "last mile" of customer interactions.
"Covisian seeks to become the global leader in customer experience services by strategically integrating GenAI into customer operations to change the way companies deliver CX," said Gabriele Moretti, Founder and Chairman at Covisian Group. "With the acquisition of Centrinex and its talented team, we are expanding our investment in the U.S. market and creating a premier showcase for Smile.CX. Our unique approach that blends human service with automated support allows agents and AI to work together to deliver seamless interactions unlike anything else on the market today."
About Covisian USA
New York-based Covisian USA, a division of Covisian Group, helps contact centers deliver exceptional customer experiences through technology that brings together the best of human intelligence, GenAI and automation. Learn more at https://covisian.com/
Story Continues
View source version on businesswire.com: https://www.businesswire.com/news/home/20241104675378/en/
Contacts
Katie Padilla
(202) 878-8315
covisian@padillaco.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TechCrunch
10 minutes ago
- TechCrunch
AI startups take to the stage to pitch their companies to a panel of judges
During the 'So You Think You Can Pitch?' event at TechCrunch Sessions: AI, three AI companies — Fluix AI, Clicka, and Narada AI — had four minutes apiece to impress judges from Initiate Ventures, Felicis, and Recursive Ventures. Each company made the case for their products, platforms, solutions, and leadership capabilities to see their vision through to the end. Fluix AI Narada AI Clicka
TechCrunch
15 minutes ago
- TechCrunch
Disruption playbook: How to beat AI incumbents at their own game
The harsh reality of the AI sector is that it's dominated by a select group of well-funded incumbents. That doesn't mean new companies can't break through, but it makes it all that much harder for them to do so. At TechCrunch Sessions: AI, Odyssey co-founder Oliver Cameron, Linear COO Cristina Cordova, and NEA partner Ann Bordetsky explored their proven strategies for finding success as they fended off formidable rivals, in a conversation moderated by AI editor Kyle Wiggers at TC Sessions: AI.
Yahoo
15 minutes ago
- Yahoo
LEADOPTIK Awarded Key Patents Across Three Continents
Strengthening Global IP Portfolio in Optical Imaging for Minimally Invasive Procedures SAN JOSE, Calif., June 6, 2025 /PRNewswire/ -- LEADOPTIK Inc., a Silicon Valley-based medical imaging company, today announced it has been awarded key patents for its proprietary optical probe across three continents: North America, Europe, and Asia. LEADOPTIK designs and manufactures optical probes for minimally invasive procedures, where two critical factors are essential: high-resolution imaging and a miniaturized form factor. High-resolution imaging enables real-time visualization of tissue microstructure, empowering clinicians with the insight needed to make more informed decisions—whether collecting biopsy samples, resecting tumor margins, or delivering therapies to targeted sites. Equally important is miniaturization. Space is at a premium during minimally invasive procedures, and LEADOPTIK's probe is designed with an exceptionally small footprint to navigate tight anatomical pathways without compromising performance. The company's innovation is powered by cutting-edge metasurface technology—flat optical components created through the fusion of nanofabrication and advanced optical design. Unlike traditional optics, metasurfaces enable ultra-thin, high-performance imaging systems that are ideal for integration into medical devices. These three newly granted patents underscore LEADOPTIK's leadership in medical imaging: U.S. Patent (#US11953698B1): Covers a novel device-level metasurface design that significantly extends imaging depth without sacrificing resolution. The patent was granted with 100% of its original claims—a testament to the novelty of LEADOPTIK's approach. European and Japanese Patents (PCT065237 & PCT029301): Protect both the current probe assembly method and alternative configurations that support expanded clinical applications. "Building robust and scalable medical devices is non-negotiable," said Reza Khorasaninejad, CEO and Co-founder of LEADOPTIK. "Our team has not only invented new optical designs but also developed novel methods of integrating them with semiconductor-grade manufacturing processes. These patents reflect our commitment to making next-generation imaging accessible, reliable, and globally protected." "Our intellectual property is the foundation of LEADOPTIK's competitive edge," said Dr. Jiang You, Co-Founder and VP of Medical Imaging. "These patents not only protect our unique optical architecture but also validate the deep technical innovation required to miniaturize high-resolution imaging. It's a major milestone that strengthens our ability to scale globally and expand into new clinical applications." About LEADOPTIK LEADOPTIK is a Silicon Valley-based company pioneering AI-enhanced real-time optical imaging at the point of biopsy. By integrating high-resolution microstructural visualization with emerging analytics, the LIA system bridges the gap between diagnosis, and therapy, supporting more precise and informed decision-making in interventional pulmonology and beyond. For more information, visit Media Contact:hello@ View original content: SOURCE LEADOPTIK Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
